作者: E. Erba , P. Ubezio , T. Colombo , M. Broggini , L. Torti
DOI: 10.1007/BF00255765
关键词: Dosing regimen 、 Pathology 、 After treatment 、 Pharmacology 、 In vivo 、 Pharmacology toxicology 、 Medicine 、 Lewis lung carcinoma 、 Dna distribution
摘要: The two dosage schedules of VP16 that gave the least and greatest efficacy in Lewis lung carcinoma mouse were selected for evaluation cytokinetic effects observable vivo at different intervals after treatment (schedule A: 40 mg/kg IV, on day 8 transplant; schedule B: 13 repeated days 8, 11 14 transplant).